MDxHealth SA ADR (MDXH) - Net Assets

Latest as of September 2025: $-8.26 Million USD

Based on the latest financial reports, MDxHealth SA ADR (MDXH) has net assets worth $-8.26 Million USD as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($154.28 Million) and total liabilities ($162.54 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check MDxHealth SA ADR liquidity resilience to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets $-8.26 Million
% of Total Assets -5.36%
Annual Growth Rate 3.8%
5-Year Change 153.74%
10-Year Change -66.47%
Growth Volatility 166.66

MDxHealth SA ADR - Net Assets Trend (2004–2024)

This chart illustrates how MDxHealth SA ADR's net assets have evolved over time, based on quarterly financial data. Also explore balance sheet size of MDxHealth SA ADR for the complete picture of this company's asset base.

Annual Net Assets for MDxHealth SA ADR (2004–2024)

The table below shows the annual net assets of MDxHealth SA ADR from 2004 to 2024. For live valuation and market cap data, see MDxHealth SA ADR (MDXH) market capitalisation.

Year Net Assets Change
2024-12-31 $14.84 Million +105.90%
2023-12-31 $7.21 Million -22.62%
2022-12-31 $9.31 Million -80.14%
2021-12-31 $46.90 Million +701.83%
2020-12-31 $5.85 Million -70.35%
2019-12-31 $19.72 Million -62.15%
2018-12-31 $52.12 Million +19.68%
2017-12-31 $43.55 Million -17.43%
2016-12-31 $52.74 Million +19.16%
2015-12-31 $44.26 Million +86.16%
2014-12-31 $23.78 Million -3.10%
2013-12-31 $24.54 Million +53.12%
2012-12-31 $16.02 Million +9.22%
2011-12-31 $14.67 Million +2.88%
2010-12-31 $14.26 Million -47.05%
2009-12-31 $26.94 Million -40.73%
2008-12-31 $45.44 Million -8.66%
2007-12-31 $49.75 Million +17.87%
2006-12-31 $42.21 Million +253.22%
2005-12-31 $11.95 Million +69.65%
2004-12-31 $7.04 Million --

Equity Component Analysis

This analysis shows how different components contribute to MDxHealth SA ADR's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 35698382117.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Common Stock $214.67 Million 1446.47%
Other Comprehensive Income $-615.00K -4.14%
Other Components $170.30 Million 1147.50%
Total Equity $14.84 Million 100.00%

MDxHealth SA ADR Competitors by Market Cap

The table below lists competitors of MDxHealth SA ADR ranked by their market capitalization.

Company Market Cap
Western Investment Company of Canada Limited
V:WI
 $111.46 Million
Eco World International Bhd
KLSE:5283
 $111.47 Million
Roots Corp
TO:ROOT
 $111.48 Million
UNICOMMERCE ESOLUTIONS LIMITED
NSE:UNIECOM
 $111.51 Million
Hariom Pipe Industries Limited
NSE:HARIOMPIPE
 $111.44 Million
Rithm Property Trust Inc.
NYSE:RPT
 $111.38 Million
Suzhou Goldengreen Technologies Ltd
SHE:002808
 $111.31 Million
PepGen Ltd
NASDAQ:PEPG
 $111.28 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in MDxHealth SA ADR's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 7,208,000 to 14,841,000, a change of 7,633,000 (105.9%).
  • Net loss of 38,069,000 reduced equity.
  • New share issuances of 40,739,000 increased equity.
  • Other comprehensive income decreased equity by 12,161,000.
  • Other factors increased equity by 17,124,000.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income $-38.07 Million -256.51%
Share Issuances $40.74 Million +274.5%
Other Comprehensive Income $-12.16 Million -81.94%
Other Changes $17.12 Million +115.38%
Total Change $- 105.90%

Book Value vs Market Value Analysis

This analysis compares MDxHealth SA ADR's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 7.12x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has increased from 0.12x to 7.12x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2004-12-31 $18.77 $2.17 x
2005-12-31 $26.15 $2.17 x
2006-12-31 $49.20 $2.17 x
2007-12-31 $46.04 $2.17 x
2008-12-31 $38.38 $2.17 x
2009-12-31 $20.44 $2.17 x
2010-12-31 $10.82 $2.17 x
2011-12-31 $8.53 $2.17 x
2012-12-31 $7.26 $2.17 x
2013-12-31 $8.17 $2.17 x
2014-12-31 $6.84 $2.17 x
2015-12-31 $10.72 $2.17 x
2016-12-31 $11.45 $2.17 x
2017-12-31 $8.72 $2.17 x
2018-12-31 $9.05 $2.17 x
2019-12-31 $3.15 $2.17 x
2020-12-31 $0.70 $2.17 x
2021-12-31 $3.85 $2.17 x
2022-12-31 $0.59 $2.17 x
2023-12-31 $0.28 $2.17 x
2024-12-31 $0.30 $2.17 x

Capital Efficiency Dashboard

This dashboard shows how efficiently MDxHealth SA ADR utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -256.51%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -42.28%
  • • Asset Turnover: 0.57x
  • • Equity Multiplier: 10.60x
  • Recent ROE (-256.51%) is below the historical average (-137.63%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2004 -99.96% -1338.66% 0.06x 1.24x $-7.75 Million
2005 -42.44% -138.98% 0.22x 1.41x $-6.27 Million
2006 -23.04% -265.90% 0.08x 1.15x $-13.95 Million
2007 -29.23% -377.70% 0.07x 1.17x $-19.52 Million
2008 -31.22% -337.04% 0.08x 1.20x $-18.73 Million
2009 -76.07% -561.26% 0.10x 1.32x $-23.18 Million
2010 -76.97% -325.43% 0.18x 1.34x $-12.40 Million
2011 -61.37% -258.54% 0.18x 1.30x $-10.47 Million
2012 -74.08% -241.36% 0.25x 1.25x $-13.47 Million
2013 -65.92% -214.12% 0.26x 1.20x $-18.63 Million
2014 -64.17% -132.90% 0.37x 1.30x $-17.63 Million
2015 -32.70% -82.86% 0.30x 1.30x $-18.90 Million
2016 -24.98% -44.11% 0.44x 1.28x $-18.45 Million
2017 -28.22% -30.33% 0.69x 1.34x $-16.64 Million
2018 -62.26% -114.51% 0.43x 1.26x $-37.66 Million
2019 -218.52% -365.72% 0.29x 2.06x $-45.07 Million
2020 -490.03% -155.27% 0.58x 5.45x $-29.25 Million
2021 -61.84% -130.41% 0.30x 1.60x $-33.69 Million
2022 -472.83% -118.86% 0.31x 12.79x $-44.98 Million
2023 -597.95% -61.40% 0.54x 17.92x $-43.82 Million
2024 -256.51% -42.28% 0.57x 10.60x $-39.55 Million

Industry Comparison

This section compares MDxHealth SA ADR's net assets metrics with peer companies in the Diagnostics & Research industry.

Industry Context

  • Industry: Diagnostics & Research
  • Average net assets among peers: $543,908,184
  • Average return on equity (ROE) among peers: -221.59%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
MDxHealth SA ADR (MDXH) $-8.26 Million -99.96% N/A $111.46 Million
Agilent Technologies Inc (A) $2.51 Billion -1.24% 2.04x $32.42 Billion
Advanced Biomed Inc. Common Stock (ADVB) $3.49 Million -115.35% 0.92x $7.19 Million
Applied DNA Sciences Inc (APDN) $11.11 Million -144.24% 0.30x $3.99 Million
Biodesix Inc (BDSX) $4.58 Million -1138.56% 20.64x $79.44 Million
bioAffinity Technologies, Inc. (BIAF) $7.28 Million -204.87% 0.51x $9.85 Million
Biocept Inc. (BIOCQ) $11.20 Million -224.43% 0.58x $262.00
BillionToOne, Inc. Class A Common Stock (BLLN) $30.47 Million -271.32% 5.29x $3.21 Billion
Burning Rock Biotech Ltd (BNR) $2.42 Billion -16.82% 0.10x $154.44 Million
CareDx Inc (CDNA) $430.91 Million -17.78% 0.26x $1.00 Billion
Check Cap Ltd (CHEK) $13.03 Million -81.27% 0.18x $9.42 Million

About MDxHealth SA ADR

NASDAQ:MDXH USA Diagnostics & Research
Market Cap
$111.46 Million
Market Cap Rank
#18764 Global
#4143 in USA
Share Price
$2.17
Change (1 day)
-4.82%
52-Week Range
$1.70 - $5.00
All Time High
$61.50
Categories
Companies in USA Diagnostics & Research
About

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. The company's testing solutions include Select mdx, a non-invasive urine test for prostate cancer that measures the expression of two mRNA cancer-related biomarkers; Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the… Read more